Lactase drops may boost weight gain in preemies
NCT ID NCT07150884
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether adding lactase enzyme drops to breast milk or formula helps premature babies (born at 28-34 weeks) gain weight. Many preemies lack enough lactase to digest lactose, which can cause diarrhea and slow growth. In this double-blind trial, 100 newborns will receive either lactase-fortified milk or regular milk, and researchers will track their weight gain, length, and head growth over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lactase enzyme drops (Delictase®)
- What this could lead to
- If it works, this could offer a simple way to help premature babies gain weight more effectively, reducing feeding problems and hospital stays.
- What could go wrong
- This is a small, early-stage trial (100 babies) and results may not apply to all premature infants. The benefit may be small or not statistically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Papageorgiou General Hospital
ACTIVE_NOT_RECRUITINGThessaloniki, Greece
-
Papageorgiou General Hospital
RECRUITINGThessaloniki, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test